Friess Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
CCA
Friess Associates's THC Position: Q2 2022 in Review
Friess Associates sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 9,890 shares — an estimated $850K sold.
Friess Associates first reported a position in THC in Q3 2014 and held it in 4 quarters. The position peaked at $4.99M in Q3 2015. 373 funds tracked by Wall St. Rank hold THC as of Q2 2022.
- Friess Associates reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
- Friess Associates sold 9,890 Tenet Healthcare shares in Q2 2022, an estimated $850K.
- Friess Associates first reported a position in Tenet Healthcare in Q3 2014 and held it in 4 quarters.
- Friess Associates's Tenet Healthcare position peaked at $4.99M in Q3 2015.
- 373 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.
Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.